Clinical trial
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
NCT00446940 · Bader, Ted, M.D., Other · Completed
Key facts
| NCT number | NCT00446940 |
|---|---|
| Title | Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C |
| Official title | Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C |
| Lead sponsor | Bader, Ted, M.D., Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | rosuvastatin, atorvastatin |
| Enrollment | 16 |
| Start date | Dec 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Mar 13, 2007 |
| Last update posted | Sep 9, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: